Discuss your research with your peers
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Discuss your research with your peers

Real time streaming news at http://www.myresearchnews.com

The website is brand new, you are helping us evolve. Please help us by contributing your thoughts on any topic, leave a comment, start a new discussion. Thanks a lot.

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency

Discuss your research with your peers :: Molecular Biology :: Antisense Forum

Go down

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency Empty Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency

Post  Jon Moulton Fri Sep 27, 2013 10:51 am

Yin H, Boisguerin P, Moulton HM, Betts C, Seow Y, Boutilier J, Wang Q, Walsh A, Lebleu B, Wood MJ. Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency. Mol Ther Nucleic Acids. 2013 Sep 24;2:e124. doi: 10.1038/mtna.2013.51.
Jon Moulton
Jon Moulton

Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA

http://www.gene-tools.com

Back to top Go down

Back to top

- Similar topics
» Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy
» Parallel Synthesis of Cell-Penetrating Peptide Conjugates of PMO Toward Exon Skipping Enhancement in Duchenne Muscular Dystrophy
» Extensive and Prolonged Restoration of Dystrophin Expression with Vivo-Morpholino-Mediated Multiple Exon Skipping in Dystrophic Dogs
» Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
» Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Discuss your research with your peers :: Molecular Biology :: Antisense Forum

 
Permissions in this forum:
You cannot reply to topics in this forum